Viridian Therapeutics Inc Earnings

The next earnings date for Viridian Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Viridian Therapeutics Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Viridian Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/05/2026	---	$-1.08	-12.99%
08/06/2025	---	$-1	0.00%
05/06/2025	Before Market	$-0.87	21.00%
02/25/2025	Before Market	$-0.81	22.43%
11/11/2024	Before Market	$-1.15	-8.92%
08/08/2024	Before Market	$-1.02	-14.61%
05/08/2024	Before Market	$-0.79	28.18%
02/27/2024	After Market	$-1.35	-35.00%
11/13/2023	After Market	$-1.09	14.17%
08/08/2023	After Market	$-1.27	1.55%
05/09/2023	After Market	$-1.61	-57.84%
03/08/2023	Before Market	$-1.13	-54.79%
11/14/2022	Before Market	$-0.86	15.69%
08/15/2022	Before Market	$-1.06	-17.78%
05/12/2022	After Market	$-0.98	9.26%
03/10/2022	After Market	$-1.32	-46.67%
11/04/2021	After Market	$-1.25	14.97%
08/11/2021	Before Market	$-2.21	-45.39%
05/06/2021	After Market	$-2.91	-282.89%
03/25/2021	After Market	$-5.31	-770.49%
11/10/2020	After Market	$-1.50	24.62%
08/05/2020	After Market	$-1.80	27.13%
05/07/2020	After Market	$-2.70	6.25%
03/11/2020	After Market	$-4.65	-23.02%
11/07/2019	After Market	$-5.40	-21.62%
08/07/2019	After Market	$-4.35	22.18%
05/08/2019	After Market	$-5.70	-10.47%
03/13/2019	After Market	$-4.95	-7.14%
11/07/2018	After Market	$-4.35	8.61%
08/07/2018	After Market	$-4.35	0.00%
05/09/2018	After Market	$-2.70	26.23%
03/14/2018	After Market	$-4.35	8.61%
11/08/2017	After Market	$-4.05	31.36%
08/11/2017	After Market	$-5.10	27.66%
05/10/2017	After Market	$-9	-150.00%
03/24/2017	After Market	$-3.45	0.00%
10/26/2016	After Market	$-3.45	---
08/15/2016	After Market	$-51.75	-24.34%
05/16/2016	Before Market	$-58.50	7.14%
03/16/2016	After Market	$-63	22.22%
11/12/2015	After Market	$-87.75	-5.41%
08/12/2015	After Market	$-74.25	15.38%
05/14/2015	After Market	$-101.25	-25.00%
03/30/2015	Before Market	$-387	-341.03%
11/14/2014	Before Market	$-96.75	-760.00%
08/08/2014	After Market	$-254.91	---

More About Viridian Therapeutics Inc

Website

https://www.viridiantherapeutics.com

Country

USA

Full Time Employees

252

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

“Viridian Therapeutics Inc Earnings” Can Refer to the Viridian Therapeutics Inc Earnings Date

Some people say “Viridian Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Viridian Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Viridian Therapeutics Inc Stock on the Earnings Date

If you own Viridian Therapeutics Inc stock (VRDN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Viridian Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Viridian Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Viridian Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Viridian Therapeutics Inc earnings or anything else related to the stock market.